Overview
This clinically oriented book is the first to be devoted wholly to the diagnosis and treatment of vitreo-macular interface disease, characterized by a combination of vitreo-macular adhesion (VMA) and vitreo-macular traction (VMT) that is implicated in a variety of disorders. World-renowned experts in the field discuss epidemiologic, anatomic, and physiologic aspects, document the findings obtained with newer imaging techniques, such as spectral domain optical coherence tomography, describe the treatment options, and report on the results of preclinical and clinical trials, including some previously unpublished findings. This book will prove invaluable for ophthalmologists as we advance toward a future in which treatments of diseases such as age-related macular degeneration and diabetic retinopathy will likely require adjunctive therapy to tackle VMA/VMT concurrently.
Full Product Details
Author: Aniz Girach ,
Marc D. de Smet
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition: Softcover reprint of the original 1st ed. 2014
Weight: 2.925kg
ISBN: 9783662521120
ISBN 10: 3662521121
Pages: 122
Publication Date: 01 October 2016
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
“This is the first book on the vitreo-macular interface and its disorders. … The book is intended for vitreoretinal surgeons, researches and other allied personnel that are interested in the topic. … This book will open a new era of investigation and implementation of knowledge regarding the wide array of vitreoretinal disorders.” (Shimon Rumelt, Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. (255), 2017)
This is the first book on the vitreo-macular interface and its disorders. ... The book is intended for vitreoretinal surgeons, researches and other allied personnel that are interested in the topic. ... This book will open a new era of investigation and implementation of knowledge regarding the wide array of vitreoretinal disorders. (Shimon Rumelt, Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. (255), 2017)
Author Information
Aniz Girach, MB.ChB., MRCOphth., MRCGP, studied at Leeds University Medical School in the United Kingdom before specializing in ophthalmology. After working in the Department of Ophthalmology, Peterborough Hospitals Trust, Cambridgeshire, Dr. Girach became Ophthalmology Consultant (Europe) for the Grand Vision Group. He then joined Eli Lilly & Co. as Senior Global Ophthalmologist and was later promoted to Global Medical Director of the Global Ophthalmology Team. He subsequently performed a similar role for Merck & Co., before becoming Vice President of International Clinical Development for Alcon Inc. and Global Head of Ophthalmology at ThromboGenics NV, Belgium. Dr. Girach has served on various scientific advisory boards and is a reviewer for several leading journals, whilst maintaining his clinical practice part-time. He is the author of many journal articles, book chapters, and other publications on Retinal diseases and other diverse issues in ophthalmology.
